Grade Post Therapy Path (yp) (Intracranial Gland (8th 2018-2022))
Organization | Field Name | ID# | ID Name | Required |
---|---|---|---|---|
KCR | Grade Post Therapy Path (yp) | 30138 | GradePostTx | yes |
SEER | Grade Post Therapy Path (yp) | gradePostTherapy | yes |
Note 1 Leave Grade Post Therapy Path (yp) blank when
No neoadjuvant therapy
Clinical or pathological case only
Neoadjuvant therapy completed; surgical resection not done
There is only one grade available, and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological
Note 2 Assign the highest grade from the resected primary tumor assessed after the completion of neoadjuvant therapy.
Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.
Note 4 Codes 1-4 take priority over A-D, L and H.
Note 5 CNS WHO classifications use a grading scheme that is a "malignancy scale" ranging across a wide variety of neoplasms rather than a strict histologic grading system that can be applied equally to all tumor types.
Code the WHO grading system for selected tumors of the CNS as noted in the AJCC 8th edition Table 72.2 when WHO grade is not documented in the record
+ A list of the histologies that have a default grade can also be found in the Brain/Spinal Cord CAP Protocol in Table 1 WHO Grading System for Some of the More Common Tumors of the CNS, Table 2 WHO Grading System for Diffuse Infiltrating Astrocytomas and Table 3 WHO Grading Meningiomas
https//www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templatesFor *benign tumors ONLY (behavior 0), * code 1 can be automatically assigned for all histologies
+ This was confirmed by the CAP Cancer Committee
Note 6 Use the grade from the post therapy clinical work up from the primary tumor in different scenarios based on behavior or surgical resection
Behavior
Tumor behavior for the post therapy clinical and the post therapy pathological diagnoses are the same AND the post therapy clinical grade is the highest grade
Tumor behavior for post therapy clinical diagnosis is invasive, and the tumor behavior for the post therapy pathological diagnosis is in situ
Surgical Resection
Surgical resection is done of the primary tumor after neoadjuvant therapy is completed and there is no grade documented from the surgical resection
Surgical resection is done of the primary tumor after neoadjuvant therapy is completed and there is no residual cancer
Note 7 Code 9 (unknown) when
Surgical resection is done after neoadjuvant therapy and grade from the primary site is not documented and there is no grade from the post therapy clinical work up
Surgical resection is done after neoadjuvant therapy and there is no residual cancer and there is no grade from the post therapy clinical work up
Grade checked "not applicable" on CAP Protocol (if available) and no other grade information is available
Code | Description |
---|---|
1 | WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection |
2 | WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence |
3 | WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course |
4 | WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination |
L | Stated as "low grade" NOS |
H | Stated as "high grade" NOS |
A | Well differentiated |
B | Moderately differentiated |
C | Poorly differentiated |
D | Undifferentiated, anaplastic |
9 | Grade cannot be assessed (GX); Unknown |
<BLANK> | See Note 1 |